The documents below contain recommendations from NICE guidance or other NICE‑accredited sources that were used by the Topic Expert Group to develop the quality standard statements and measures.
Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012) NICE guideline CG144
Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism (2012) NICE technology appraisal guidance 261
It is important that the quality standard is considered alongside current policy documents, including:
Department of Health (2010) Venous thromboembolism (VTE) risk assessment
Department of Health (2009) Venous thromboembolism prevention: a patient safety priority
Department of Health (2008) Using the commissioning for quality and innovation (CQUIN) payment framework (see 'Guidance on national goals for 2011–12')